Quipt Home Medical Corp.(QIPT)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

Quipt Home Medical Corp. (QIPT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores QIPT at 41.4/100 on a 32-signal composite quality model, placing it at rank #1,958 of 2,856 stocks — the bottom half of the AI-ranked universe. QIPT scores in the top quartile across earnings quality (90.7). Areas of concern include revenue scale (21.2) and profitability (23.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2025), Quipt Home Medical Corp. reports quarterly revenue of $81.0M, net income of $-1.1M, an operating margin of 1.3%. Top institutional holders of QIPT by reported 13-F value include Forager Capital Management, Claret Asset Management, GLAZER CAPITAL, based on the most recent SEC filings. QIPT trades on the Nasdaq exchange and files with the SEC under CIK 1540013. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QIPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quipt Home Medical Corp. directly from SEC EDGAR.